Latest filing published 06 Nov 2026 for Vericel Corp, €29k.
Filing timeline
BuySaleInsider track record
Robert L. Zerbe MD: trading record in brief
Robert L. Zerbe MD, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Vericel Corp, Heron Therapeutics, Inc. /DE/ and Optimer Pharmaceuticals Inc. The record holds 56 filings, for trades running from 16 January 2006 to 5 November 2026.
On the market, this insider has only sold: 20 sales, €2.0M in total. The rest of the record consists of 13 share grants and 21 option exercises. 2026 to date brings no purchases and 3 sales.
Most recently, on 6 November 2026, the filings show an option exercise worth €29k in Vericel Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert L. Zerbe MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$13.05Common StockSEC:0001140361-26-042462:0
- 2,500 shares@ US$45.40Common StockSEC:0001140361-26-042462:1
- 500 shares@ US$13.05Common StockSEC:0001140361-26-042462:2
- 500 shares@ US$55.00Common StockSEC:0001140361-26-042462:3
- 2,500 shares@ US$13.05Common StockSEC:0001140361-26-042462:4
- 2,500 shares@ US$51.67Common StockSEC:0001140361-26-042462:5
- 3,200 sharesCommon StockSEC:0001140361-26-018541:0
- 3,200 sharesCommon StockSEC:0001140361-25-017114:0
- 2,500 shares@ US$62.507.4% of flowCommon StockSEC:0001140361-25-003571:1
- 2,500 shares@ US$13.055.7% of flowCommon StockSEC:0001140361-25-003571:0
- 2,500 shares@ US$60.007.1% of flowCommon StockSEC:0001140361-24-047758:1
- 2,500 shares@ US$13.055.7% of flowCommon StockSEC:0001140361-24-047758:0
- 2,500 shares@ US$55.006.3% of flowCommon StockSEC:0001140361-24-046456:1
- 2,500 shares@ US$13.051.5% of flowCommon StockSEC:0001140361-24-046456:2
- 2,500 shares@ US$57.506.7% of flowCommon StockSEC:0001140361-24-046456:3
- 2,500 shares@ US$13.055.5% of flowCommon StockSEC:0001140361-24-046456:0
- 3,200 sharesCommon StockSEC:0001140361-24-024334:0
- 3,278 shares@ US$51.577.7% of flowCommon StockSEC:0001140361-24-016591:1
- 3,278 shares@ US$3.742.1% of flowCommon StockSEC:0001140361-24-016591:0
- 722 shares@ US$50.011.7% of flowCommon StockSEC:0001140361-24-009033:1
- 722 shares@ US$3.740.5% of flowCommon StockSEC:0001140361-24-009033:0
- 2,300 shares@ US$44.2217.0% of flowCommon StockSEC:0001140361-24-004549:0
- 200 shares@ US$44.021.5% of flowCommon StockSEC:0001140361-24-004270:0
- 2,500 shares@ US$42.064.8% of flowCommon StockSEC:0001140361-24-003663:1
- 3,000 shares@ US$4.120.6% of flowCommon StockSEC:0001140361-24-003663:2
25 of 50 declarations
